![](/img/cover-not-exists.png)
Strong decrease of patients with advanced liver disease and more adherence problems to HCV therapy as DAA regimen enter third year of existence in Germany
Petersen, J., Wursthorn, K., Olah, K., Lorenzen, T., Plettenberg, A., Unger, S., Czaja-Harder, C., Burchard, A., Matschenz, K., Stoehr, A., Buggisch, P.Volume:
66
Year:
2017
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(17)31446-0
File:
PDF, 79 KB
english, 2017